FDA Approval Preempts DePuy Knee Device Suit, Judge Says

Law360, New York (March 18, 2013, 10:36 PM EDT) -- Johnson & Johnson unit DePuy Orthopaedics Inc. on Monday dodged a product liability suit alleging its P.F.C. Sigma Rotating Platform Knee device was defective when a New Jersey federal judge found that the claims are preempted by the U.S. Food and Drug Administration’s approval process.

U.S. District Judge Joel Pisano granted summary judgment to DePuy, ruling that that the claims by Michael Smith — a knee replacement patient who had the P.F.C. Sigma Rotating Platform Knee implanted in his right leg — were preempted by the...
To view the full article, register now.

Documents

Related

Sections

Case Information

Case Title

SMITH v. DEPUY ORTHOPAEDICS, INC. et al


Case Number

3:11-cv-04139

Court

New Jersey

Nature of Suit

Personal Inj. Prod. Liability

Judge

Joel A. Pisano

Date Filed

July 19, 2011

Law Firms

Companies

Government Agencies

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.